Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Soligenix Inc (NASDAQ:SNGX) announced the results of a booster vaccination study using CiVax (heat-stable COVID-19 subunit vaccine program) in non-human primates (NHPs).
- The data demonstrated rapid enhancement of neutralizing antibody responses to SARS-CoV-2, including against Delta and Omicron variants.
- The NHPs had been double vaccinated with an adenovirus vaccine for COVID-19 seven months previously.
- Before administering the booster vaccine, neutralizing antibody levels against the original and Delta strains were low but detectable and undetectable for the omicron strain.
- Within one week of receiving the booster, neutralizing antibody levels increased 27-fold against the original and Delta strains. By three weeks, this increased up to 243-fold.
- Protective neutralizing antibody levels were also rapidly raised against omicron by one-week post-vaccination.
- Price Action: SNGX shares are up 0.99% at $0.69 during the market session on the last check Thursday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!